Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Blue Jet Healthcare Limited
BLUEJETBlue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, Spain, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India. Address: Bhumiraj Costarica, Plot No. 1 & 2, Thane, India, 400705
Analytics
Zielpreis von Wall Street
44 325.93 INRKGV
55.8851Dividendenrendite
0.19 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen BLUEJET
Dividenden-Analyse BLUEJET
Dividendenwachstum über 5 Jahre
–Kontinuierliches Wachstum
–Ausschüttungsquote 5-Jahres-Durchschnitt
–Verlauf der Dividende BLUEJET
Bewertung der Aktie BLUEJET
Finanzen BLUEJET
Ergebnisse | 2019 | Dynamik |